Dr. Amy Flaster, Cigna Healthcare’s chief medical officer since last year, is stepping up as CMO of the whole enterprise. At ...
More than 450 telehealth and provider organizations are pushing lawmakers to avoid another temporary extension of ...
More than 70% reported moderate to severe financial effects from an incident in the past two years, while nearly 60% cited ...
The company is considering selling assets that could be more easily separated from the rest of the business without creating ...
The Medicare giant likes what it’s seen in the first two weeks of open enrollment. But there are steps it can take if ...
Leaders are worried some of the sector’s persistent challenges — like finance pressures and worker burnout — could worsen ...
Researchers said the results suggest UnitedHealth may be sidestepping government rules meant to keep a lid on exorbitant ...
Prospect Medical Holdings is seeking approval from a bankruptcy court to close its hospitals in Rhode Island. Regulators and ...
Former Congressional Budget Office Director Dan Crippen argues the 340B discount program is overdue for reform.
Drugs that will be subject to rebates in 340B next year include Bristol Myers Squibb’s Eliquis, Johnson & Johnson’s Stelara ...
Fewer than 30% of health system leaders said they earned significant return on investment from virtual care offerings, ...
The $600 million deal was foreshadowed during the company’s third quarter earnings call this month, when CEO Kevin Hammons ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback